Treatment of elastosis perforans serpiginosa with the 585-nm pulsed dye laser
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Elastosis perforans serpiginosa (EPS) is a rare disorder showing erythematous or skin-colored hyperkeratotic papules with a serpiginous or arcuate distribution. There are various treatment modalities available, but a standard treatment method has not been established. We report the case of a 33-year-old male patient with a 2-month history of grouped, multiple, annular-shaped, scaly erythematous papules on his right anterior neck. A histopathological analysis revealed increased brightly eosinophilic elastic fibers from the papillary dermis through the epidermis and clutching the dermis at the site of the perforation of the elastic fibers. Immunohistochemical analysis revealed abnormal elastic fibers with transepidermal elimination in the papillary dermis on the elastic stain. Based on these features, the lesion was diagnosed as EPS. After treatment with six sessions of the 585-nm pulsed dye laser over 3 weeks, the lesion was cleared without any adverse events and no recurrence was observed 2 months after therapy.
Abstract
Elastosis perforans serpiginosa (EPS) is a rare disorder showing erythematous or skin-colored hyperkeratotic papules with a serpiginous or arcuate distribution. There are various treatment modalities available, but a standard treatment method has not been established. We report the case of a 33-year-old male patient with a 2-month history of grouped, multiple, annular-shaped, scaly erythematous papules on his right anterior neck. A histopathological analysis revealed increased brightly eosinophilic elastic fibers from the papillary dermis through the epidermis and clutching the dermis at the site of the perforation of the elastic fibers. Immunohistochemical analysis revealed abnormal elastic fibers with transepidermal elimination in the papillary dermis on the elastic stain. Based on these features, the lesion was diagnosed as EPS. After treatment with six sessions of the 585-nm pulsed dye laser over 3 weeks, the lesion was cleared without any adverse events and no recurrence was observed 2 months after therapy.
참고문헌 (15)
- Woo TY, "Disorders of transepidermal elimination. Part 1", Int J Dermatol, 24, pp.267~279 (1985)
- Saxena M, "Response of elastosis perforans serpiginosa to pulsed CO2, Er : YAG, and dye lasers", Dermatol Surg, 29, pp.677~678 (2003)
- Rosenblum GA, "Liquid nitrogen cryotherapy in a case of elastosis perforans serpiginosa", J Am Acad Dermatol, 8, pp.718~721 (1983)
- Outland JD, "Tazarotene is an effective therapy for elastosis perforans serpiginosa", Arch Dermatol, 138, pp.169~171 (2002)
- Ratnavel RC, "Penicillamine-induced elastosis perforans serpiginosa treated successfully with isotretinoin", Dermatology, 189, pp.81~83 (1994)
- Langeveld-Wildschut EG, "Familial elastosis perforans serpiginosa", Arch Dermatol, 129, pp.205~207 (1993)
- Lewis KG, "Acquired disorders of elastic tissue : part I. Increased elastic tissue and solar elastotic syndromes", J Am Acad Dermatol, 51, pp.1~21 (2004)
- Montesu MA, "Elastosis perforans serpiginosa : causes and associated disorders", Eur J Dermatol, 28, pp.476~481 (2018)
- Yang JH, "Treatment of elastosis perforans serpiginosa with the pinhole method using a carbon dioxide laser", Dermatol Surg, 37, pp.524~526 (2011)
- Kelati A, "Treatment of elastosis perforans serpiginosa using a fractional carbon dioxide laser", JAMA Dermatol, 153, pp.1063~1064 (2017)
- Kaufman AJ, "Treatment of elastosis perforans serpiginosa with the flashlamp pulsed dye laser", Dermatol Surg, 26, pp.1060~1062 (2000)
- Rinaldi G, "Pulse dye laser therapy successful for elastosis perforans serpiginosa", Case Rep Dermatol Med, 2019, pp.2860746~ (2019)
- Bjerring P, "Dermal collagen production following irradiation by dye laser and broadband light source", J Cosmet Laser Ther, 4, pp.39~43 (2002)
- Nehal KS, "Treatment of mature striae with the pulsed dye laser", J Cutan Laser Ther, 1, pp.41~44 (1999)
- Zelickson BD, "Pulsed dye laser therapy for sun damaged skin", Lasers Surg Med, 25, pp.229~236 (1999)